Associate Prof., Hefei university of technology, China
Dr. Mei Luo, born in 1969 in Bozhou, Anhui Province, is an esteemed Associate Professor in the Department of Chemistry at Hefei University of Technology (HFUT), where she currently serves in Room 713 of the Shenghua Building. With a career rooted in both academic excellence and groundbreaking research, Dr. Luo has contributed significantly to the fields of organic and organometallic chemistry. She is the proud holder of over 200 patents—a testament to her inventive spirit and dedication to advancing chemical science. Her work spans internationally renowned institutions, including postdoctoral roles and visiting scholarships in China and the United States.
🔹Professional Profile
Scopus Profile
🏆Strengths for the Award
-
Extensive Research Experience and Academic Background:
Mei Luo has a strong academic background with a Ph.D. in Chemistry from a prestigious institution (University of Science and Technology of China), followed by multiple postdoctoral appointments at leading universities, including Peking University and the University of Utah.
-
Significant Research Contributions:
She has authored numerous high-impact publications in reputable journals covering synthesis, characterization, and biological activities of organometallic complexes, reflecting a sustained and productive research output over several years. Her work spans both fundamental chemistry and applied research, particularly in drug synthesis and anticancer activities.
-
Innovation and Patents:
With over 200 patents granted since 2006, Mei Luo demonstrates outstanding innovation and practical impact in her field, a critical factor for high recognition in research.
-
Collaborative and Interdisciplinary Work:
Her collaborations with international researchers and contributions to diverse subfields such as organic chemistry, organometallic chemistry, and medicinal chemistry showcase her ability to bridge disciplines, a valued trait in modern research.
-
Leadership and Teaching:
As an Associate Professor, she contributes to teaching and mentoring, helping cultivate future researchers, which adds to her holistic contribution to academia.
🎓 Education
Dr. Luo’s academic journey began at Hefei University of Technology, where she completed her Master’s degree in Chemical Engineering from 1996 to 1999. She then went on to earn her Ph.D. in Chemistry from the prestigious University of Science and Technology of China (USTC) in 2005. Her thirst for knowledge and excellence led her to postdoctoral research positions at Peking University (2005–2006), the University of Utah (2014–2015) and later as a visiting scholar at the University of North Carolina at Chapel Hill (2017–2019). These international experiences enriched her research skills and opened new avenues for collaborative scientific inquiry.
💼 Experience
Prof. Luo currently serves as an Associate Professor at Hefei University of Technology, where she teaches courses such as Organic Chemistry and Organic Structure Analysis. Her classes are renowned for their clarity, rigor, and relevance to real-world applications, often integrating insights from her own research.Over the years, she has also actively collaborated with global researchers and mentored numerous graduate students, contributing significantly to the development of scientific talent in China. Her professional demeanor, coupled with a tireless work ethic, has earned her respect across academic and industrial spheres.
Dr. Luo’s research focuses primarily on the synthesis of chiral organometallic complexes, drug development, and transition metal-based anticancer agents. Her work stands at the interface of inorganic chemistry, synthetic methodology, and medicinal applications. She has pioneered novel sulfur-containing and heterocyclic metal complexes, exploring their structure, reactivity, and biological activity. A major theme across her research is the rational design of molecules for catalysis and therapeutic use, especially those showing promising anticancer properties.
📚 Publications Top Notes
Synthesis, Characterization, and Cytotoxicity Research of Sulfur-Containing Metal Complexes
Year: 2025
Authors: Mei Luo, et al.
Summary:
In this study, Prof. Luo and her team synthesized a new class of sulfur-containing transition metal complexes and systematically characterized their molecular structure, bonding, and reactivity using techniques such as NMR, IR, and X-ray crystallography. The complexes were then evaluated for cytotoxic activity against human cancer cell lines, revealing promising anticancer potential due to the interaction of sulfur donor atoms with cellular biomolecules. This research contributes valuable insight into the design of metal-based chemotherapeutics, especially for targeting sulfur-active biological pathways.
Synthesis, Crystal Structure and Anticancer Activity of 4‑Chloro-2-Methoxybenzoic Acid Transition Metal Complexes
Year: 2024
Authors: Mei Luo, et al.
Summary:
This article presents the synthesis and crystal structure of transition metal complexes derived from 4-chloro-2-methoxybenzoic acid, with metals including copper, cobalt, and zinc. Structural elucidation was performed using single-crystal X-ray diffraction, while biological studies focused on their anticancer efficacy. Results showed significant cytotoxicity, particularly from the copper complex, offering a new direction in the development of benzoic acid-based anticancer agents.
Zn(II), Cu(II), Co(II), and Ni(II) Complexes Bearing Aza-Heterocyclic Ligands: Synthesis, Characterization, and Anticancer Activities
Journal: Journal of the Iranian Chemical Society
Year: 2024
Authors: Mei Luo, et al.
Summary:
This research explores the coordination chemistry of transition metals (Zn, Cu, Co, Ni) with aza-heterocyclic ligands, which are known for their strong metal-binding properties and biological relevance. Prof. Luo’s team carried out structural, spectroscopic, and biological evaluation, including UV-Vis, FTIR, and elemental analysis, followed by in vitro cytotoxic screening. The results highlighted the enhanced anticancer activity of the Zn(II) and Cu(II) complexes, indicating their potential as lead compounds for further drug development.
Unveiling the Hidden Reactivity in the N-Heterocyclic Carbene-Catalyzed Aerobic Oxidation of Aldehydes: Unlocking Its Powerful Catalytic Performance
Year: 2024
Authors: Mei Luo, et al.
Summary:
In this article, Prof. Luo investigates the mechanistic aspects of N-heterocyclic carbene (NHC)-catalyzed aerobic oxidation reactions. The study reveals previously unrecognized reactive intermediates involved in the catalytic cycle. Utilizing computational modeling and experimental validation, the team demonstrates how these species influence reaction efficiency and selectivity. This paper not only deepens the understanding of NHC catalysis but also proposes improvements for greener oxidation strategies in organic synthesis.
🧭 Conclusion
Dr. Mei Luo exemplifies the rare fusion of scientific innovation, international collaboration, and academic mentorship. Her impactful research on organometallic complexes, especially in the realm of anticancer agents, holds tremendous promise for medical applications. Her consistent excellence in scholarship, teaching, and intellectual property makes her a truly deserving nominee for any distinguished award in science and education. 🌍🔬📖